Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia

Cancer Genetics and Cytogenetics

Volumn 187, Issue 2, 2008, Pages 125-129

  Han, Yongsheng ^a   Xue, Yongquan ^a   Zhang, Jun ^a   Wu, Yafang ^a   Pan, Jinlan ^a   Wang, Yong ^a   Shen, Juan ^a   Dai, Haiping ^a   Bai, Shuxiao ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CD19 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; HLA DR ANTIGEN; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CEBPE GENE; CHROMOSOME 11Q; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 14; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; IGH GENE; IMMUNOPHENOTYPING; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CCAAT-ENHANCER-BINDING PROTEINS; CHROMOSOMES, HUMAN, PAIR 14; DAUNORUBICIN; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; TRANSLOCATION, GENETIC; TRISOMY; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 56249124285     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.08.008     Document Type: Article

References (18)

1. Taylor A.M.R., Metcalfe J.A., Thick J., and Mak Y.F. Leukemia and lymphoma in ataxia telangiectasia. Blood 87 (1996) 423-438
2. Matutes E., Brito-Babapulle V., Swansbury J., Ellis J., Morilla R., Dearden C., Sempere A., and Catovsky D. Clinical and laboratory feature of 78 cases of T-prolymphocytic leukemia. Blood 78 (1991) 3269-3274
3. Sadamori N., Nishino K., Kusano M., Tomonaga Y., Tagawa M., Yao E.I., Sasagawa I., Nakamura H., and Ichimaru M. Significance of chromosome 14 anomaly at band 14q11 in Japanese patients with adult T-cell leukemia. Cancer 58 (1986) 2244-2250
4. Matutes E., and Catovsky D. Mature T-cell leukemia and leukemia/lymphoma syndromes: review of our experience in 175 cases. Leuk Lymphoma 4 (1991) 81-91
5. Matutes E., Talavera J.G., O'Brien M., and Catovsky D. The morphological spectrum of T-prolymphocytic leukemia. Br J Haematol 64 (1986) 111-124
6. Pekarsky Y., Hallas C., and Croce C.M. The role of TCL1 in human T-cell leukemia. Oncogene 20 (2001) 5638-5643
7. Davey M.P., Bertness V., Nakahara K., Johnson J.P., McBride O.W., Waldmann T.A., and Kirsch I.R. Juxtaposition of the T-cell receptor alpha-chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 14;14 translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia-telangiectasia. Proc Natl Acad Sci USA 85 (1988) 9287-9291
8. Virgilio L., Narducci M.G., Isobe M., Billips L.G., Cooper M.D., Croce C.M., and Russo G. Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci USA 91 (1994) 12530-12534
9. Pekarsky Y., Hallas C., and Corce C.M. Molecular basis of mature T-cell leukemia. JAMA 286 (2001) 2308-2314
10. Mengle-Gaw L., Albertson D.G., Sherrington P.D., and Rabbitts T.H. Analysis of a T-cell tumor-specific breakpoint cluster at human chromosome 14q32. Proc Natl Acad Sci USA 85 (1988) 9171-9175
11. Raimondi S.C., Zhou Y., Mathew S., Shurtleff S.A., Rivera G.K., Behm F.G., and Pui C.H. Reassessment of the prognostic significance of hyperdiploidy in pediatric patients with acute lymphoblastic leukemia. Cancer 98 (2003) 2715-2722
12. Berger R., Busson M., and Daniel M.T. B-cell acute lymphoblastic leukemia with tandem t(14;14)(q11;q32). Cancer Genet Cytogenet 130 (2001) 84-86
13. Liu S., Bo L., Liu X., Li C., and Qin S. Wang J.IGH gene involvement in two cases of acute lymphoblastic leukemia with t(14;14)(q11;q32) identified by sequential R-banding and fluorescence in situ hybridization. Cancer Genet Cytogenet 152 (2004) 141-145
14. Akasaka T., Balasas T., Russell L.J., Sugimoto K.J., Majid A., Walewska R., Karran E.L., Brown D.G., Cain K., Harder L., Gesk S., Martin-Subero J.I., Atherton M.G., Bruggemann M., Calasanz M.J., Davies T., Haas O.A., Hagemeijer A., Kempski H., Lessard M., Lillington D.M., Moore S., Nguyen-Khac F., Radford-Weiss I., Schoch C., Struski S., Talley P., Welham M.J., Worley H., Strefford J.C., Harrison C.J., Siebert R., and Dyer M.J.S. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 109 (2007) 3451-3461
15. In: Shaffer L.G., and Tommerup N. (Eds). An international system for human cytogenetic nomenclature (ISCN 2005) (2005), S Karger, Basel
16. Li T., Xue Y., Wu Y., and Pan J. Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-). Br J Haematol 125 (2004) 337-342
17. Lekstrom-Himes J.A. The role of C/EBPE in the terminal stages of granulocyte differentiation. Stem Cells 19 (2001) 125-133
18. Truong B.T.H., Lee Y.J., Lodie T.A., Park D.J., Perrotti D., Watanabe N., Koeffler H.P., Nakajima H., Tenen D.G., and Kogan S. CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia. Blood 101 (2003) 1141-1148